Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | R2-ISS in newly diagnosed multiple myeloma: real-world experience

Jelena Bila, MD, PhD, University of Belgrade, Belgrade, Serbia, discusses the use of the second revision of the International Staging System (R2-ISS) in patients with newly diagnosed multiple myeloma (NDMM) in the real-world setting. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.